Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

2275.95

20-Dec-2024

Open
High
Low
Previous Close

2325.00
2326.30
2264.00
2326.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

85491
1960.56
3088.00
1748.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

38,700.81
57.33
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

37,590.80
1.40%
23.14

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.27
1.38
1.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.69
6.69
3.59

PAT CAGR (%)

10 Years
5 Years
3 Years

2.16
44.64
15.71

P:E (Median)

8 Years
5 Years
3 Years

60.86
56.40
42.61

P:BV (Average)

8 Years
5 Years
3 Years

14.73
16.79
17.24

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.27
30.69
29.92

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 34.83 50.63 58.22 64.05
P/E Ratio 68.49 47.12 40.98 37.24
Revenue 3454 3739 4149 4455
EBITDA 909 1104 1255 1345
Net Income 590 858 986 1085
ROA 17.1 32.7 35.7
P/Bk Ratio 22.73 19.72 16.53 13.13
ROE 33.53 43.81 42.98 38.4
FCFF 644 833.87 1081.92 1158.29
FCFF Yield 1.66 2.16 2.8 2.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,000.05 953.38 4.90% 811.00 738.02 9.89% 910.87 782.16 16.46% 804.98 799.11 0.73%
Expenses 681.10 666.80 2.14% 581.58 596.77 -2.55% 655.56 615.40 6.53% 587.47 571.31 2.83%
EBITDA 318.95 286.58 11.30% 229.42 141.25 62.42% 255.31 166.76 53.10% 217.51 227.80 -4.52%
EBIDTM 31.89% 30.06% 28.29% 19.14% 28.03% 21.32% 27.02% 28.51%
Other Income 32.19 28.47 13.07% 35.85 36.80 -2.58% 29.87 27.97 6.79% 28.34 23.60 20.08%
Interest 0.27 0.43 -37.21% 0.37 0.28 32.14% 0.77 0.65 18.46% 0.32 0.09 255.56%
Depreciation 16.86 18.11 -6.90% 16.41 16.36 0.31% 18.10 17.18 5.36% 17.11 16.41 4.27%
PBT 338.70 296.51 14.23% 248.49 178.71 39.05% 268.71 187.30 43.47% 65.11 223.53 -70.87%
Tax 90.01 80.97 11.16% 66.84 48.13 38.87% 75.63 55.82 35.49% 19.62 59.50 -67.03%
PAT 248.69 215.54 15.38% 181.65 130.58 39.11% 193.08 131.48 46.85% 45.49 164.03 -72.27%
PATM 24.87% 22.61% 22.40% 17.69% 21.20% 16.81% 5.65% 20.53%
EPS 14.68 12.72 15.41% 10.72 7.71 39.04% 11.40 7.76 46.91% 2.69 9.68 -72.21%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,010.77 956.99 5.62% 814.65 761.66 6.96% 929.80 787.45 18.08% 805.26 802.30 0.37%
Expenses 689.06 667.50 3.23% 584.11 617.78 -5.45% 672.54 617.71 8.88% 587.20 573.60 2.37%
EBITDA 321.71 289.49 11.13% 230.54 143.88 60.23% 257.26 169.74 51.56% 218.06 228.70 -4.65%
EBIDTM 31.83% 30.25% 28.30% 18.89% 27.67% 21.56% 27.08% 28.51%
Other Income 34.54 28.21 22.44% 35.64 36.44 -2.20% 29.83 27.66 7.85% 28.11 23.42 20.03%
Interest 0.27 0.43 -37.21% 0.37 0.28 32.14% 0.77 0.65 18.46% 0.32 0.09 255.56%
Depreciation 16.86 18.11 -6.90% 16.41 16.36 0.31% 18.10 17.18 5.36% 17.11 16.41 4.27%
PBT 343.81 299.16 14.93% 249.40 180.98 37.81% 270.62 189.97 42.45% 65.43 224.25 -70.82%
Tax 91.31 81.65 11.83% 67.07 48.73 37.64% 76.14 56.54 34.67% 19.71 59.69 -66.98%
PAT 252.50 217.51 16.09% 182.33 132.25 37.87% 194.48 133.43 45.75% 45.72 164.56 -72.22%
PATM 24.98% 22.73% 22.38% 17.36% 20.92% 16.94% 5.68% 20.51%
EPS 14.90 12.84 16.04% 10.76 7.81 37.77% 11.48 7.88 45.69% 2.70 9.71 -72.19%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,526.90 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 Net Sales Growth 7.77% 5.94% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% Cost Of Goods Sold 1,332.52 1,288.43 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 Gross Profit 2,194.38 2,118.82 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 GP Margin 62.22% 62.19% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% Total Expenditure 2,505.71 2,506.60 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.87% 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.33% 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 % Of Sales - 3.33% 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% General & Admin Exp. - 190.48 189.33 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 % Of Sales - 5.59% 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.88 164.26 222.32 % Of Sales - 5.41% 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% Miscellaneous Exp. - 75.82 72.95 64.17 78.51 111.89 106.88 104.29 96.61 125.19 222.32 % Of Sales - 2.23% 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% EBITDA 1,021.19 900.65 799.42 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 EBITDA Margin 28.95% 26.43% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% Other Income 126.25 123.48 101.51 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 Interest 1.73 1.80 1.81 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation 68.48 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT 921.01 952.65 833.36 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 Tax 252.10 224.35 227.69 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 Tax Rate 27.37% 27.73% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% PAT 668.91 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 PAT before Minority Interest 668.91 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.97% 17.16% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% PAT Growth 4.25% -3.31% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% EPS 39.49 34.52 35.70 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,560.48 3,453.71 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 Net Sales Growth 7.62% 6.21% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% Cost Of Goods Sold 1,363.73 1,334.53 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 Gross Profit 2,196.75 2,119.18 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 GP Margin 61.70% 61.36% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% Total Expenditure 2,532.91 2,545.02 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 Power & Fuel Cost - 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 % Of Sales - 0.86% 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% Employee Cost - 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 % Of Sales - 18.08% 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% Manufacturing Exp. - 113.61 99.05 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 % Of Sales - 3.29% 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% General & Admin Exp. - 190.50 189.33 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 % Of Sales - 5.52% 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% Selling & Distn. Exp. - 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.91 164.47 222.31 % Of Sales - 5.33% 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% Miscellaneous Exp. - 68.13 68.62 58.09 75.74 112.58 107.20 105.12 98.67 127.99 222.31 % Of Sales - 1.97% 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% EBITDA 1,027.57 908.69 804.28 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 EBITDA Margin 28.86% 26.31% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% Other Income 128.12 122.59 100.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 Interest 1.73 1.80 1.81 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 Depreciation 68.48 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 PBT 929.26 959.80 837.37 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 Tax 254.23 226.23 228.76 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 Tax Rate 27.36% 27.72% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% PAT 675.03 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 PAT before Minority Interest 675.03 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.96% 17.08% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% PAT Growth 4.21% -2.91% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% EPS 39.85 34.83 35.87 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,784.09 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,623.69 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 Non-Current Liabilities 106.82 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 246.21 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 Current Liabilities 1,510.94 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 Trade Payables 613.24 418.56 555.45 447.99 354.19 402.96 502.53 275.92 323.09 305.89 Other Current Liabilities 205.60 184.47 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 Total Liabilities 3,401.85 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 Gross Block 663.27 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 Accumulated Depreciation 342.91 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 196.13 Non Current Assets 636.01 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 24.49 24.49 24.49 25.82 25.97 26.17 49.43 52.99 53.63 47.67 Long Term Loans & Adv. 275.12 351.98 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 Other Non Current Assets 1.22 1.08 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 Current Assets 2,765.84 2,466.72 3,670.60 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 514.29 437.70 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,061.20 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 Other Current Assets 155.07 155.40 79.55 218.22 107.54 1,578.61 1,585.33 332.19 121.90 197.99 Short Term Loans & Adv. 24.68 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 Net Current Assets 1,254.90 1,149.69 1,996.24 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 Total Assets 3,401.85 3,194.52 4,509.70 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,777.64 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 Total Reserves 1,617.24 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 Non-Current Liabilities 107.72 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 Long Term Provisions 247.46 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 Current Liabilities 1,524.95 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 Trade Payables 625.41 427.79 579.33 466.13 357.06 405.81 505.86 278.93 327.74 308.04 Other Current Liabilities 207.44 184.59 503.74 450.11 222.85 802.71 842.35 390.47 202.82 130.09 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 692.10 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 Total Liabilities 3,410.31 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 Net Block 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 Gross Block 680.87 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 Accumulated Depreciation 360.52 304.79 262.20 215.09 695.76 129.06 83.08 46.38 24.32 240.26 Non Current Assets 611.89 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 Capital Work in Progress 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 Non Current Investment 0.00 0.00 0.00 1.35 1.49 1.69 1.84 5.40 6.04 0.06 Long Term Loans & Adv. 275.44 347.40 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 Other Non Current Assets 1.24 1.10 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 Current Assets 2,798.42 2,494.26 3,707.92 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 Current Investments 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 525.05 459.97 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 Sundry Debtors 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 Cash & Bank 1,063.22 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 Other Current Assets 174.87 155.48 89.49 225.89 108.85 1,580.88 1,591.97 338.90 333.82 200.47 Short Term Loans & Adv. 24.68 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 Net Current Assets 1,273.47 1,167.89 2,009.49 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 Total Assets 3,410.31 3,193.03 4,520.02 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 578.94 487.94 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 PBT 952.65 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 Adjustment -46.14 -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 Changes in Working Capital 64.55 -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 Cash after chg. in Working capital 971.06 757.61 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.67 -262.86 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 14.97 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 333.11 989.73 -47.11 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 Cash from Financing Activity -561.50 -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 32.41 -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 Opening Cash & Equivalents 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 Closing Cash & Equivalent 62.15 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 582.02 484.23 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 PBT 959.80 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 Adjustment -45.13 -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 Changes in Working Capital 61.02 -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 Cash after chg. in Working capital 975.69 755.75 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -254.23 -264.71 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -139.45 -6.81 -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 Cash From Investing Activity 8.71 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 Net Fixed Assets -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 Net Investments -294.93 -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 Others 326.85 992.39 -32.96 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 Cash from Financing Activity -561.50 -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 Net Cash Inflow / Outflow 29.23 -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 Opening Cash & Equivalents 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 Closing Cash & Equivalent 64.17 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.85 103.58 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 ROA 17.73% 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% ROE 32.96% 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% ROCE 45.85% 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% Fixed Asset Turnover 5.76 5.77 5.93 3.04 3.21 6.48 8.22 11.35 10.32 11.16 Receivable days 20.23 20.54 21.73 18.45 12.47 15.60 20.03 18.12 14.65 10.40 Inventory Days 46.48 49.10 53.51 58.87 54.87 57.56 58.34 57.72 57.50 37.61 Payable days 146.15 142.20 141.33 117.18 57.46 72.90 65.55 50.91 53.40 43.13 Cash Conversion Cycle -79.44 -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 450.79 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 105.47 102.89 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 ROA 17.87% 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% ROE 33.43% 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% ROCE 46.49% 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% Fixed Asset Turnover 5.25 5.31 6.03 3.04 3.21 6.48 8.21 11.38 9.59 9.82 Receivable days 21.90 22.32 21.37 18.42 12.47 15.60 20.03 18.09 14.59 10.35 Inventory Days 52.05 55.82 54.91 60.14 54.88 57.56 58.36 57.89 57.97 38.01 Payable days 144.03 143.05 140.69 119.53 57.89 73.24 66.07 51.56 53.81 43.72 Cash Conversion Cycle -70.08 -64.91 -64.41 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 454.77 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26

Top Investors:

life insurance corporation of india - p & gs fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
29th Oct 2024, 15:44 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback